Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
- DOI
- 10.1016/j.jbspin.2025.105882
- Published
- 2025-03-14
- Container
- Joint Bone Spine
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jbspin.2025.105882,
title = {Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.},
author = {Ayano M and Ueda N and Mishima K and Ota SI and Kushimoto K and Tanaka A and Doi G and Nakayama T and Maekawa M and Tsuru T and Akahoshi M and Akashi K and Horiuchi T and Niiro H.},
year = {2025},
journal = {Joint Bone Spine},
doi = {10.1016/j.jbspin.2025.105882},
url = {https://doi.org/10.1016/j.jbspin.2025.105882}
}RIS
TY - JOUR TI - Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry. AU - Ayano M AU - Ueda N AU - Mishima K AU - Ota SI AU - Kushimoto K AU - Tanaka A AU - Doi G AU - Nakayama T AU - Maekawa M AU - Tsuru T AU - Akahoshi M AU - Akashi K AU - Horiuchi T AU - Niiro H. PY - 2025 JO - Joint Bone Spine DO - 10.1016/j.jbspin.2025.105882 UR - https://doi.org/10.1016/j.jbspin.2025.105882 ER -
APA
M, A., N, U., K, M., SI, O., K, K., A, T., G, D., T, N., M, M., T, T., M, A., K, A., T, H., & H., N. (2025). Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2025.105882
Source records
- europe-pmc · retrieved 2026-09-27T03:48:22.428Z